Search

everythinglearnresearchcommunity

for

Search:↓

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

The polyherbal ointment made from plant extracts was safe and effectively promoted hair growth in rats.

Cyclosporine combined with other treatments can help hair regrow in severe alopecia areata, but it may cause side effects.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Salicylic acid ointment effectively treated a toddler's skin condition.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Three related Persian cats have a rare, likely hereditary skin condition causing hair loss and poor coat quality, with limited treatment options.

Baricitinib may help people with long-term alopecia areata.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Intralesional steroid therapy is useful for treating various skin conditions.

Ocimum oil may promote hair growth and reduce hair loss from cyclophosphamide.

The combination therapy was effective and well-tolerated, especially in young patients.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

A 12-year-old boy's hair loss and skin issues improved significantly with medication.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Touching cats can increase the risk of getting a fungal scalp infection, especially in boys and kids over 5.

Vitamin B12 and aureomycin reduce the negative effects of high doses of cortisone in rats.

Some elderly men had healing problems after using imiquimod and diclofenac for skin conditions on their scalps.

The gel with icariin speeds up wound healing, reduces scarring, and helps hair growth by controlling BMP4 signaling. It also reduces inflammation and improves wound quality in mice, adapts to different wound shapes, and gradually releases icariin to aid healing. It also prevents too much collagen and myofibroblast formation during skin healing.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.